Fox Trial Finder Revamped to Help More Enroll in Clinical Trials

Fox Trial Finder Revamped to Help More Enroll in Clinical Trials
4.7
(3)

To make it easier for Parkinson’s (PD) patients and healthy volunteers to take part in clinical trials, The Michael J. Fox Foundation for Parkinson’s Research (MJFF) is introducing a redesigned version of its Fox Trial Finder clinical study matching tool.

“At the Foundation, our single urgent goal is to eliminate Parkinson’s disease,” Sohini Chowdhury, MJFF’s deputy CEO, said in a press release. “It will take the efforts of all of us to better connect the millions impacted by the disease worldwide to opportunities that could advance breakthroughs in treatments and ultimately a cure.”

Chowdhury said the new online Fox Trial Finder will help offset the burden of trial recruitment. Due to a lack of volunteers, 85% of clinical studies face delays, and some 30% never get started, she added.

The finder is powered by WCG’s CenterWatch iConnect platform for ease of use. WCG provides services and technologies aimed at improving clinical trial quality and efficiency.

iConnect also lets trial sponsors establish and manage recruitment efforts from one platform, enabling them to gauge each part of each study’s enrollment strategy. The potential result is better predictability and lower outreach costs.

“We are proud to be accelerating research and moving our mission forward to get safer, more effective treatments into the hands of patients living with Parkinson’s disease as efficiently as possible while maintaining the highest quality and ethical research standards,” said Donald A. Deieso, PhD, executive chairman and CEO of WCG. “MJFF’s decision to redesign its new Fox Trial Finder on our iConnect platform will make clinical research much more accessible and easier to navigate for patients and their families.”

Touted as having the world’s most expansive roster of recruiting clinical trials, WCG CenterWatch iConnect is visited monthly by more than 250,000 people seeking information about studies for themselves or others. In addition, the platform falls in the top three of most study-related search results overall.

“MJFF’s Fox Trial Finder has traditionally been one of the gold standards in matching patients to clinical trials,” said Lisa LaLuna, WCG’s senior vice president for patient advocacy. “We are honored to provide MJFF with a more user-friendly version for their Parkinson’s community of patients, families and supporters around the globe.”

Anyone wishing to try the new trial matching tool can go here. At the site, visitors may search for applicable disorders — currently, it reports that 412 Parkinson’s trials are recruiting — and get general information about clinical investigations.

An estimated seven to 10 million individuals globally have Parkinson’s, the most common age-related neurodegenerative disease after Alzheimer’s.

The Foundation funds Parkinson’s research with a goal of finding a cure for Parkinson’s, and better therapies until then.

Mary M. Chapman began her professional career at United Press International, running both print and broadcast desks. She then became a Michigan correspondent for what is now Bloomberg BNA, where she mainly covered the automotive industry plus legal, tax and regulatory issues. A member of the Automotive Press Association and one of a relatively small number of women on the car beat, Chapman has discussed the automotive industry multiple times of National Public Radio, and in 2014 was selected as an honorary judge at the prestigious Cobble Beach Concours d’Elegance. She has written for numerous national outlets including Time, People, Al-Jazeera America, Fortune, Daily Beast, MSN.com, Newsweek, The Detroit News and Detroit Free Press. The winner of the Society of Professional Journalists award for outstanding reporting, Chapman has had dozens of articles in The New York Times, including two on the coveted front page. She has completed a manuscript about centenarian car enthusiast Margaret Dunning, titled “Belle of the Concours.”
Total Posts: 208
Ana holds a PhD in Immunology from the University of Lisbon and worked as a postdoctoral researcher at Instituto de Medicina Molecular (iMM) in Lisbon, Portugal. She graduated with a BSc in Genetics from the University of Newcastle and received a Masters in Biomolecular Archaeology from the University of Manchester, England. After leaving the lab to pursue a career in Science Communication, she served as the Director of Science Communication at iMM.
×
Mary M. Chapman began her professional career at United Press International, running both print and broadcast desks. She then became a Michigan correspondent for what is now Bloomberg BNA, where she mainly covered the automotive industry plus legal, tax and regulatory issues. A member of the Automotive Press Association and one of a relatively small number of women on the car beat, Chapman has discussed the automotive industry multiple times of National Public Radio, and in 2014 was selected as an honorary judge at the prestigious Cobble Beach Concours d’Elegance. She has written for numerous national outlets including Time, People, Al-Jazeera America, Fortune, Daily Beast, MSN.com, Newsweek, The Detroit News and Detroit Free Press. The winner of the Society of Professional Journalists award for outstanding reporting, Chapman has had dozens of articles in The New York Times, including two on the coveted front page. She has completed a manuscript about centenarian car enthusiast Margaret Dunning, titled “Belle of the Concours.”
Latest Posts
  • Grant's Army
  • COVID-19 and Parkinson's
  • Sidekicks program
  • caregiver summit

How useful was this post?

Click on a star to rate it!

Average rating 4.7 / 5. Vote count: 3

No votes so far! Be the first to rate this post.

As you found this post useful...

Follow us on social media!

We are sorry that this post was not useful for you!

Let us improve this post!

Tell us how we can improve this post?